1156 Deaths Following COVID Vaccination In The Country: Govt

New Delhi : Rajasthan has reported 36 deaths following COVID-19 vaccination till March 15, 2023, according to a reply provided by the Union government in the Lok Sabha last week.
The state also witnessed 1737 Adverse Events Following Immunisation (AEFI), following COVID vaccination, the Union ministry of health and family welfare said in reply to a question by Kuruva Gorantla Madhav, a YSR Congress MP from Andhra Pradesh.

Country witnessed 92,479 cases of  Minor, Severe & Serious AEFI cases following COVID-19 vaccination reported till 15th March 2023.

The MP had sought details of the state-wise number of AEFI, including minor, severe and serious cases and the number of AEFI-related deaths. In his reply, the minister of state for health and family welfare Bharati Pravin Pawar said AEFI cases of COVID vaccines are reported and monitored through a well-structured and robust AEFI surveillance system under the Universal Immunisation Program.

For the reporting of COVID vaccination-related AEFIs, the SAFEVAC (a web-based application for AEFI) is integrated into CoWin and reporting of AEFIs is done through the Co-Win SAFEVAC. The app has the provision of reporting AEFIs by the vaccinator, district immunization officer and the beneficiary themselves.

According to the written reply, a total of 1,156 deaths following vaccination have been reported in the country. Kerala reported the highest deaths at 244. Maharashtra (102), Uttar Pradesh (86) and Madhya Pradesh (85) are the other states that reported more deaths than Karnataka.

Asked about the particulars of the AEFI cases, health commissioner D Randeep said he has sought details from the officials in the health department.
  • Related Posts

    • Pharma
    • April 11, 2025
    • 142 views
    Aurobindo Pharma shares jump 4% as arm completes phase1 trial for bone drug

    Aurobindo Pharma shares jumped 5 per cent on Friday, April 11, 2025, logging an intraday high at ₹1,110 per share on BSE. The stock rallied after the company’s subsidiary, CuraTeQ…

    • Pharma
    • April 11, 2025
    • 111 views
    ‘Pharma companies need to look beyond US market’

    HYDERABAD:  With the Trump administration’s flip-flops on tariffs giving the Indian pharma industry a headache, experts feel it’s time the sector looked at an ‘America plus’ strategy to reduce heavy…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Aurobindo Pharma shares jump 4% as arm completes phase1 trial for bone drug

    Aurobindo Pharma shares jump 4% as arm completes phase1 trial for bone drug

    ‘Pharma companies need to look beyond US market’

    ‘Pharma companies need to look beyond US market’

    HC upholds validity of Bihar pharmacist rules

    HC upholds validity of Bihar pharmacist rules

    CAHOCON 2025 marks Highest Point in Quest for Culture of Patient Safety

    CAHOCON 2025 marks Highest Point in Quest for Culture of Patient Safety